Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Metachronous contralateral recurrence in upper tract urothelial carcinoma: a multi-institutional competing-risks analysis from the ROBUUST 3.0 registry.

Urology practice·2026

Same author

Phase 2 Trial of Intravesical Gemcitabine and Docetaxel as First-Line Treatment of Bacillus Calmette-Guérin (BCG)‒Naïve Nonmuscle-Invasive Urothelial Carcinoma: Updated, 3-Year Outcomes.

The Journal of urology·2026

Same author

1H MR-based detection of human plasma metabolic alterations in clear cell renal cell carcinoma.

BJUI compass·2026

Same author

Renal function outcomes following endoscopic management of upper tract urothelial carcinoma.

World journal of urology·2026

Same author

Patterns of adjuvant intracavitary instillation and recurrence after endoscopic management of upper tract urothelial carcinoma.

World journal of urology·2026

Same author

Presentation, management, and outcomes of testicular germ cell tumors by age.

Urologic oncology·2026

Same journal

Role and relevance of genetic testing in patients with kidney stones: a review from EAU Section of Endourology.

Current opinion in urology·2026

Same journal

Advances in evaluating and delivering nontechnical skills training: The use of simulation, robotics, artificial intelligence and virtual reality.

Current opinion in urology·2026

Same journal

Educating for a sustainable future: faculty and student perspectives and a review of environmental sustainability in medical education - an EAU endourology study.

Current opinion in urology·2026

Same journal

Shaping the future of endourology: role of education, simulation and uro-technology: a scoping review by the EAU Section of Endourology.

Current opinion in urology·2026

Same journal

A review of emerging technologies and techniques for percutaneous nephrolithotomy access.

Current opinion in urology·2026

Same journal

Artificial intelligence in kidney cancer: a review of clinical applications across the disease spectrum.

Current opinion in urology·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Mar 24, 2026

Thermal Ablation for the Treatment of Abdominal Tumors

Thermal Ablation for the Treatment of Abdominal Tumors

Published on: March 7, 2011

New technologies in tumor ablation.

Nirmish Singla¹, Jeffrey Gahan

¹aUT Southwestern Medical Center bUT Southwestern Medical Center, VA North Texas Health System, Dallas, Texas, USA.

Current Opinion in Urology

|March 12, 2016

Summary

This summary is machine-generated.

Newer ablation technologies like microwave ablation and irreversible electroporation show promise for treating small renal masses. Further research is needed to optimize their use alongside established methods such as radiofrequency ablation and cryoablation.

More Related Videos

Focal Laser Ablation of Prostate Cancer: An Office Procedure

Focal Laser Ablation of Prostate Cancer: An Office Procedure

Published on: March 30, 2021

Evaluation of the Feasibility, Safety, and Accuracy of an Intraoperative High-intensity Focused Ultrasound Device for Treating Liver Metastases

Evaluation of the Feasibility, Safety, and Accuracy of an Intraoperative High-intensity Focused Ultrasound Device for Treating Liver Metastases

Published on: January 9, 2019

Related Experiment Videos

Last Updated: Mar 24, 2026

Thermal Ablation for the Treatment of Abdominal Tumors

Thermal Ablation for the Treatment of Abdominal Tumors

Published on: March 7, 2011

Focal Laser Ablation of Prostate Cancer: An Office Procedure

Focal Laser Ablation of Prostate Cancer: An Office Procedure

Published on: March 30, 2021

Evaluation of the Feasibility, Safety, and Accuracy of an Intraoperative High-intensity Focused Ultrasound Device for Treating Liver Metastases

Evaluation of the Feasibility, Safety, and Accuracy of an Intraoperative High-intensity Focused Ultrasound Device for Treating Liver Metastases

Published on: January 9, 2019

Area of Science:

Urology
Minimally Invasive Surgery
Oncology

Background:

Ablative techniques are increasingly used for small renal masses.
Several technologies are under investigation for renal mass treatment.

Purpose of the Study:

To review new and emerging ablative technologies for small renal masses.
To familiarize clinicians with these evolving treatment options.

Main Methods:

Review of current literature on ablative modalities for renal masses.
Focus on emerging technologies including microwave ablation and irreversible electroporation.
Comparison with established techniques like radiofrequency ablation and cryoablation.

Main Results:

Radiofrequency ablation and cryoablation remain the most studied ablative methods.
Microwave ablation and irreversible electroporation offer theoretical benefits but require further study.
Other emerging options like stereotactic radiation and focused ultrasound have limited supporting data.

Conclusions:

Ablation technology for renal masses is rapidly advancing.
Newer modalities like microwave ablation and irreversible electroporation hold promise.
Optimal tumor characteristics and device settings for newer ablative techniques require further investigation.